We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$26B
AUM Growth
+$2.52B
(+11%)
Cap. Flow
+$734M
Cap. Flow
% of AUM
2.83%
Top 10 Holdings %
Top 10 Hldgs %
21.08%
Holding
3,430
New
246
Increased
1,548
Reduced
1,426
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$25.4M |
| 2 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$22.8M |
| 3 |
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
|
+$22.2M |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$21.2M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$25M |
| 2 |
First Trust Value Line Dividend Fund
FVD
|
+$22.1M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.2M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18M |
| 5 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.99% |
| 2 | Financials | 5.01% |
| 3 | Consumer Discretionary | 4.04% |
| 4 | Healthcare | 3.7% |
| 5 | Industrials | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
GSK
GSK
$101B
| $6.39M | 0.02% |
149,169
-1,245
| -0.8% | -$51.3K |
|
627
Vanguard International High Dividend Yield ETF
VYMI
$21.3B
| $6.38M | 0.02% |
92,795
+10,619
| +13% | +$708K |
|
628
First Trust Managed Municipal ETF
FMB
$2.06B
| $6.35M | 0.02% |
123,705
+9,463
| +8% | +$487K |
|
629
IQ MacKay Municipal Insured ETF
MMIN
$478M
| $6.33M | 0.02% |
260,668
+5,145
| +2% | +$125K |
|
630
Black Stone Minerals
BSM
$3.08B
| $6.32M | 0.02% |
395,296
-379
| -0.1% | -$6K |
|
|
PHK
631
PIMCO High Income Fund
PHK
$875M
| $6.31M | 0.02% |
1,276,861
+146,183
| +13% | +$720K |
|
632
Xcel Energy
XEL
$49.1B
| $6.28M | 0.02% |
116,768
+590
| +0.5% | +$33.7K |
|
633
VanEck IG Floating Rate ETF
FLTR
$3.04B
| $6.24M | 0.02% |
244,745
+27,098
| +12% | +$687K |
|
634
Dimensional US Marketwide Value ETF
DFUV
$15.9B
| $6.24M | 0.02% |
152,441
-52,355
| -26% | -$2M |
|
|
635
Invesco S&P 500 Pure Value ETF
RPV
$1.73B
| $6.22M | 0.02% |
70,385
-196,742
| -74% | -$16.3M |
|
636
Rio Tinto
RIO
$165B
| $6.22M | 0.02% |
97,576
-1,019
| -1% | -$68.2K |
|
637
Schwab Short-Term US Treasury ETF
SCHO
$12.9B
| $6.21M | 0.02% |
257,606
-75,476
| -23% | -$1.82M |
|
638
Invesco S&P Global Water Index ETF
CGW
$1.07B
| $6.19M | 0.02% |
111,397
-331
| -0.3% | -$17.5K |
|
639
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.11B
| $6.19M | 0.02% |
213,895
-40,847
| -16% | -$1.18M |
|
640
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
| $6.18M | 0.02% |
144,319
+138,235
| +2,272% | +$5.83M |
|
641
Arbor Realty Trust
ABR
$974M
| $6.17M | 0.02% |
465,575
+113,116
| +32% | +$1.52M |
|
642
abrdn Physical Silver Shares ETF
SIVR
$4.53B
| $6.16M | 0.02% |
258,563
-103,340
| -29% | -$2.31M |
|
643
Avantis US Equity ETF
AVUS
$14.4B
| $6.14M | 0.02% |
68,582
+5,982
| +10% | +$505K |
|
644
FT Vest Fund of Nasdaq-100 Buffer ETFs
BUFQ
$1.57B
| $6.13M | 0.02% |
216,563
+50,193
| +30% | +$1.39M |
|
645
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
| $6.13M | 0.02% |
144,096
-6,759
| -4% | -$286K |
|
646
Freedom 100 Emerging Markets ETF
FRDM
$3.41B
| $6.12M | 0.02% |
181,373
+122,154
| +206% | +$3.91M |
|
647
MetLife
MET
$61.4B
| $6.12M | 0.02% |
82,539
+4,040
| +5% | +$282K |
|
648
Williams Companies
WMB
$90.1B
| $6.09M | 0.02% |
156,240
-19,591
| -11% | -$696K |
|
649
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.21B
| $6.08M | 0.02% |
212,054
-6,013
| -3% | -$162K |
|
650
AstraZeneca
AZN
$246B
| $6.08M | 0.02% |
44,866
-3,851
| -8% | -$510K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Cambridge Investment Research Advisors held 3,430 positions worth $26B, up 11% from $23.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Cambridge Investment Research Advisors's Q1 2024 filing shows 246 new, 1,548 increased, 1,426 reduced and 128 closed positions. Its largest new stake was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M. The largest sale was Apple, an estimated $25M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q1 2024 buy was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M.
- Cambridge Investment Research Advisors added most to Vanguard Total Bond Market in Q1 2024, an estimated $25.4M increase.
- Cambridge Investment Research Advisors's biggest Q1 2024 reduction was Apple, cutting an estimated $25M.
- Cambridge Investment Research Advisors fully exited iMGP RBA Responsible Global Allocation ETF in Q1 2024, selling an estimated $3.97M.
- Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $26B portfolio in Q1 2024.
- Cambridge Investment Research Advisors opened 246 new positions and closed 128 in Q1 2024.
- Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $26B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.